On-Demand Webinars

Forging a Path for Early Clinical Development in Sickle Cell Disease

Distinguished Pfizer researchers David Beidler and Debra Pittman share their experience in Sickle Cell Disease including: Using longitudinal biomarker data from early clinical development decision in sickle cell disease (SCD) Building the patient perspective into clinical trials: development of the vaso-occlusive crisis (VOC) day endpoint through the use of the electronic patient-reported outcomes (ePRO) Bring it all together in ELIPSIS: a natural history study to evaluate longitudinal changes in ePRO, actigraphy, and biomarkers in SCD patients   Transcript Speaker 1: Today.